3-Methoxybutyl formate | 5437-07-0

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: 3-Methoxybutyl formate
• CAS: 5437-07-0
• 化学式: C₆H₁₂O₃
• 分子量: 132.16
• InChiKey: CYCHJWNSQZCRIA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.8
• 重原子数：
  9
• 可旋转键数：
  5
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.83
• 拓扑面积：
  35.5
• 氢给体数：
  0
• 氢受体数：
  3

文献信息

• [EN] POLYMERIZABLE COMPOSITION COMPRISING AN OXIME SULFONATE AS THERMAL CURING AGENT<br/>[FR] COMPOSITION POLYMÉRISABLE COMPRENANT UN SULFONATE D'OXIME EN TANT QU'AGENT DE DURCISSEMENT THERMIQUE
  申请人：BASF SE

  公开号：WO2012101245A1

  公开（公告）日：2012-08-02

  The present invention relates to a polymerizable composition comprising at least one ethylenically unsaturated, polymerizable compound and at least one oxime sulfonate compound of the formula (I) QAaBbCc where a is 0, 1, 2, 3, 4 or 6, b is 0, 1, 2, 3, 4 or 6, and c is 0, 1, 2, 3, 4 or 6, where the sum of a + b + c is 1, 2, 3, 4 or 6 where (A) is a group (B) is a group (C) is a group where # denotes the point of attachment to Q; X is S or NR14 and Q, R1, R2, R3 and R14 are as defined in claim 1 and in the description. The present invention also relates to the use of the this composition, to novel oxime sulfonates and the use of the oxime sulfonates as thermal curing promoter.

  本发明涉及一种可聚合的组成，包括至少一种乙炔基不饱和的可聚合化合物和至少一种具有公式（I）QAaBbCc的亚硝基亚磺酸酯化合物，其中a为0、1、2、3、4或6，b为0、1、2、3、4或6，c为0、1、2、3、4或6，其中a+b+c的总和为1、2、3、4或6，其中（A）是一个基团，（B）是一个基团，（C）是一个基团，其中#表示与Q连接的点；X是S或NR14，Q、R1、R2、R3和R14如权利要求1和说明书中所定义。本发明还涉及使用这种组成物，新型亚硝基亚磺酸酯及其作为热固化促进剂的应用。
• [EN] SULFONIUM SULFATES, THEIR PREPARATION AND USE<br/>[FR] SULFATES DE SULFONIUM, LEUR PRÉPARATION ET UTILISATION
  申请人：BASF SE

  公开号：WO2012113829A1

  公开（公告）日：2012-08-30

  The present invention relates to a heat-curable composition comprising (a) at least one compound which is capable of undergoing cationic polymerization; and (b) at least one sulfonium sulfate selected from compounds of the formulae Ia and Ib where Yn- is a monovalent or divalent anion selected from (1) where n, M, R1 to R10 are as defined in claim 1 and in the description. The present invention also relates to novel sulfonium sulfates of the formulae Ia and Ib, to a process for curing cationically polymerizable material and to the cured material obtained by said process.

  本发明涉及一种热固化组合物，包括（a）至少一种能够进行阳离子聚合的化合物；和（b）选择自式Ia和Ib的至少一种砜酸盐，其中Yn-是从（1）中选择的一价或二价阴离子，其中n、M、R1至R10如权利要求1和描述中所定义。本发明还涉及式Ia和Ib的新型砜酸盐，以及用于固化阳离子聚合材料的工艺和通过该工艺获得的固化材料。
• [EN] PEPTIDIC COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS<br/>[FR] COMPOSES PEPTIDIQUES EN TANT QU'INHIBITEURS DE LA PROTEASE A CYSTEINE
  申请人：AXYS PHARM INC

  公开号：WO2004000838A1

  公开（公告）日：2003-12-31

  The present invention is directed to compounds that are inhibitors of cysteine proteases, in particular, cathepsins B, K, L, F, and S and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceutical compositions comprising these compounds and processes for preparing them.

  本发明涉及一种抑制半胱氨酸蛋白酶的化合物，特别是卡特普辛B、K、L、F和S，因此在治疗由这些蛋白酶介导的疾病方面具有用途。本发明涉及包含这些化合物的药物组合物以及制备它们的方法。
• SULFONIUM COMPOUNDS, THEIR PREPARATION AND USE
  申请人：BASF SE

  公开号：US20150044509A1

  公开（公告）日：2015-02-12

  Compounds of the formula (I), (Ia) or (Ib) wherein A 1 , and A − is for example (II) is 1 or 2; X is C 1 -C 4 alkylene or CO; Y is for example O, O(CO), O(CO)O, R 1 is for example hydrogen, d-dsalkyl, C 3 -C 30 cycloalkyl, phenyl, naphthyl, anthracyl, phenanthryl, biphenylyl, fluorenyl or C 3 -C 20 heteroaryl, all of which optionally are substituted; R 2 and R 3 for example are C 1 -C 10 haloalkylene which is optionally substituted, or R 2 and R 3 are phenylene, which optionally is substituted; R 4 is a group (A) or a group (B); R 5 and R 6 for example are C 1 -C 20 alkyl; or R 4 and R 5 or R 4 and R 6 together form a straight-chain C 2 -C 6 alkylene, R 5 and R 6 together form a straight-chain C 2 -C 6 alkylene; R 7 , R 8 , R 9 and R 10 ifor example are C 1 -C 20 alkyl; M for example is C 1 -C 20 alkylene, C 2 -C 20 alkenylene, C 2 -C 20 alkynylene; R 25 and R 26 are for example hydrogen, C 1 -C 20 alkyl; R 27 , R 28 , R 29 , R 30 and R 31 are for example hydrogen, C 1 -C 20 alkyl, C 2 -C 20 alkenyl, C 3 -C 20 cycloalkyl, or two radicals R 27 and R 28 , R 28 and R 29 , R 29 and R 30 and/or R 30 and R 31 together form a straight-chain C 2 -C 6 alkylene, or R 25 and R 27 together form 1,2-phenylene, R 33 and R 34 for example are hydrogen, C 1 -C 20 alkyl; R 35 , R 36 and R 37 for example are hydrogen, C 1 -C 20 alkyl; are suitable as thermo-acid generators.

  化合物的公式(I)、(Ia)或(Ib)，其中A1和A-例如(II)为1或2；X为C1-C4烷基或CO；Y例如为O、O(CO)、O(CO)O、R1例如为氢、d-ds烷基、C3-C30环烷基、苯基、萘基、蒽基、菲基、联苯基、芴基或C3-C20杂环芳基，全部可选地被取代；R2和R3例如为可选地被取代的C1-C10卤代烷基，或R2和R3为苯基，可选地被取代；R4为(A)基团或(B)基团；R5和R6例如为C1-C20烷基；或R4和R5或R4和R6一起形成直链C2-C6烷基，R5和R6一起形成直链C2-C6烷基；R7、R8、R9和R10例如为C1-C20烷基；M例如为C1-C20烷基、C2-C20烯基、C2-C20炔基；R25和R26例如为氢、C1-C20烷基；R27、R28、R29、R30和R31例如为氢、C1-C20烷基、C2-C20烯基、C3-C20环烷基，或两个基团R27和R28、R28和R29、R29和R30和/或R30和R31一起形成直链C2-C6烷基，或R25和R27一起形成1,2-苯基，R33和R34例如为氢、C1-C20烷基；R35、R36和R37例如为氢、C1-C20烷基；适用于热酸发生器。
• Peptidic compounds as cysteine protease inhibitors
  申请人：AXYS PHARMACEUTICALS, INC.

  公开号：US20040127426A1

  公开（公告）日：2004-07-01

  The present invention is directed to compounds that are inhibitors of cysteine proteases, in particular, cathepsins B, K, L, F, and S and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceutical compositions comprising these compounds and processes for preparing them.

  本发明涉及一种抑制半胱氨酸蛋白酶的化合物，特别是抑制B、K、L、F和S型猫蛋白酶，因此可用于治疗由这些蛋白酶介导的疾病。本发明涉及包含这些化合物的制药组合物和其制备方法。